The State of Immune Reactivity During the Treatment of Genital Herpes in Patients Who Have Undergone Covid-19

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/3289

Full metadata record

DC Field	Value	Language
dc.contributor.author	Guli A. Ismailova, Firuza B. Mirodilova, Nodira S. Saipova, Farkhod F. Hashimov, Gayratillo Sh. Tokhtaev, Azizbek F. Valijonov, Shirina A. Valijonova.	-
dc.date.accessioned	2022-10-11T13:51:27Z	-
dc.date.available	2022-10-11T13:51:27Z	-
dc.date.issued	2022	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/3289	-
dc.description.abstract	Relapses of herpes simplex during the COVID-19 pandemic in patients with or without respiratory symptoms alarm us about the possibility of SARS-CoV-2 infection in these patients. Both the stress caused during the pandemic and the invasion of SARS-CoV-2 itself are generative elements of immunodeficiency in humans, a situation that can be used by the herpes virus to reactivate and infect the host .	en_US
dc.language.iso	en	en_US
dc.publisher	Other	en_US
dc.subject	SARS-CoV-2, Recurrent Genital Herpes, HSV-1, HSV-2.	en_US
dc.title	The State of Immune Reactivity During the Treatment of Genital Herpes in Patients Who Have Undergone Covid-19	en_US
dc.type	Article	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
2.1. Исмаилова Г.А..pdf	The State of Immune Reactivity During the Treatment of Genital Herpes in Patients Who Have Undergone Covid-19	186.33 kB	Adobe PDF	View/Open

DSpace JSPUI